Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNAs (miRNAs) regulating bone metabolism constitute a large and functionally diverse group of small (~22 nucleotide) non-coding RNAs that modulate gene expression at the post-transcriptional level. They play critical roles in bone development, remodeling, and homeostasis by influencing processes such as osteoblast and osteoclast differentiation, bone matrix formation, and bone resorption through the regulation of mRNA translation and degradation. Individual miRNAs (e.g., miR-21, miR-155, miR-133a, miR-214, miR-206) target distinct genes and signaling pathways central to bone cell function and skeletal disease. The field is of high translational interest, but the term "microRNA regulating bone metabolism" encompasses a class of molecules rather than a specific druggable target, complicating both therapeutic development and structured data extraction[1][2][3][4][5].
Antagomirs (antisense oligonucleotides inhibiting specific miRNAs); miRNA mimics (restoring functional levels of deficient miRNAs); Modulation of miRNA activity through exosome delivery or gene editing
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA regulating bone metabolism (miRNA).